|
2540
|
Akt Inhibitor VIII
|
Inhibitor of Akt1 and 2 with significant off-side effects (CaMKIα and AhR) |
€95.00 |
|
2541
|
APD 597
|
Orally bioavailable selective GPR119 agonist |
€125.00 |
|
2523
|
BX 430
|
Allosteric antagonist of human P2X4 receptor channels |
€105.00 |
|
2533
|
Hydroxypioglitazone
|
Active metabolite of Pioglitazone (M-IV), a PPARγ agonist |
€180.00 |
|
2530
|
OTX 015
|
Potent inhibitor of BRD2, BRD3, and BRD4 with clear anti-proliferative activity |
€110.00 |
|
2483
|
PF 05105679
|
TRPM8 inhibitor with >100-fold selectivity and in vivo activity in humans |
€95.00 |
|
2545
|
PF 06260933 dihydrochloride
|
Potent and selective MAP4K4 inhibitor |
€85.00 |
|
2546
|
PF 06447475
|
Potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor |
€85.00 |
|
2488
|
Piperlongumine
|
Natural alkaloid with potent cytotoxic activity |
€65.00 |
|
2539
|
Solcitinib
|
Selective JAK1 inhibitor for treatment of degenerative and inflammatory diseases |
€90.00 |
|
2518
|
UF 010
|
Class I selective HDAC inhibitor that inhibits cancer cell proliferation |
€60.00 |